Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 175,920
Cost of revenue	(153,630)
Gross profit	22,290
Operating expenses:
General and administrative	4,698,624	4,622,624
Selling and marketing	296,461	213,738
Research and development	266,864	335,445
Total operating expenses	5,261,949	5,171,807
Operating loss	(5,239,659)	(5,171,807)
Other income/(expense)
Other income	15,832	19,046
Gain on settlement	3,206,000
Interest expense	(1,212,667)	(403,578)
Total other income/(expense)	2,009,165	(384,532)
Loss before provision for income taxes	(3,230,494)	(5,556,339)
Provision for income taxes
Net loss	(3,230,494)	(5,556,339)
Preferred stock dividends	(34,005)	(34,005)
Net loss attributable to common stockholders	$ (3,264,499)	$ (5,590,344)
Net loss attributable to common stockholders per common share – basic and diluted (in Dollars per share)	$ (0.02)	$ (0.03)
Weighted average number of common shares outstanding, basic and diluted (in Shares)	193,505,618	204,486,058